Guidepoint Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guidepoint global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guidepoint Global Today - Breaking & Trending Today

Novel immunotherapy agent safe, shows promise

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. If confirmed in additional studies, enoblituzumab could become the first promising antibody-based immunotherapy agent against prostate cancer. ....

United States , Johns Hopkins University , Charlesg Drake , Samuelr Denmeade , Johns Hopkins , Tamaral Lotan , Eli Lilly , Kennethj Pienta , Hogkai Ji , Emmanuels Antonarakis , Carolyn Chapman , Christianp Pavlovich , Eugene Shenderov , Zhao Wang , Mohamad El Allaf , Oncology At Janssen Research , Johns Hopkins Kimmel Cancer Center , Prostate Cancer Foundation Young Investigator Award , Northwestern University Feinberg School Of Medicine , Department Of Defense , Johns Hopkins University School Of Medicine , University Of Minnesota Antonaraki , Bristol Myers Squibb , Bloomberg Kimmel Institute For Cancer Immunotherapy , Nanostring Technologies Inc , Macrogenics Inc ,